Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in sy...
Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from...
Truist Securities analyst David Macdonald maintains Quest Diagnostics (NYSE:DGX) with a Hold and raises the price target fro...
Leerink Partners analyst Michael Cherny maintains Quest Diagnostics (NYSE:DGX) with a Outperform and raises the price target...
Shares of Quest Diagnostics (NASDAQ: DGX) are falling Tuesday after the medical laboratories company shared mixed earnings resu...
Gold prices suffered a sharp correction on Tuesday as investors locked in profits following this year's explosive rally, wh...
Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $2.60 per share which beat the analyst consensus estimate of $2.50 ...
